Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

23 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Companies

Top Ten Companies // Browse A - Z of companies

  • Merck KGaA (Merck)
  • Merck (Merck KGaA)
  • Pfizer
  • Roche
  • Novartis
  • GlaxoSmithKline (GSK)
  • GSK (GlaxoSmithKline)
  • Bristol-Myers Squibb
  • Lilly
  • Bayer

Browse the A - Z of Companies

  • #
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

F

  • F-Star
  • Facet Biotech
  • Faes Farma
  • Fagron
  • Fanghui Pharmaceuticals
  • Farma-Projekt
  • Farmacol
  • Farmadiet
  • Farmak
  • Farmeks
  • Farmimeks
  • Farmsintez
  • Fate Therapeutics
  • FDA
  • FDS Pharma
  • Fenwal
  • Fero Industries
  • Ferrer Internacional
  • Ferring Pharmaceuticals
  • Ferro Group
  • FerroKin BioSciences
  • Ferrosan
  • FineTech Pharmaceutical
  • Finoso Pharma
  • Finotech Pharma
  • Fiocruz
  • FIT-BioCeuticals
  • FivePrime Therapeutics
  • FKD Therapies
  • Flamel Technologies
  • FlexLink
  • FoldRx
  • Footstar
  • Foresee Pharmaceuticals
  • Forest Laboratories
  • Forest Pharmaceuticals
  • FORMA Therapeutics
  • Fosun Omni Pharma
  • Fosun Pharma
  • Fougera Pharmaceuticals
  • Foundation Medicine
  • Fournier
  • Freedom Pharmaceuticals
  • Fresenius
  • Fresenius Biotech
  • Fresenius Kabi
  • Frik Ilac
  • Frontage Laboratories
  • Fuji Pharma
  • Fujifilm Diosynth Biotechnologies
  • Fujifilm Kyowa Kirin Biologics
  • Fujisawa Pharmaceutical
  • Functional Technologies
  • Fundacion MEDINA
  • Funxional Therapeutics
  • Furiex Pharmaceuticals
  • FusionVax
  • Futura Medical
  • Hot Topics
  • Most Read
  • Boehringer Ingelheim gets FDA warning letter on cGMP failures
  • AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
  • US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
  • Italy's pharma market slump set to continue, warns GlobalData
  • Is failure to adopt business process management putting the pharma industry at risk?
  • Boehringer Ingelheim gets FDA warning letter on cGMP failures
  • AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
  • US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
  • Italy's pharma market slump set to continue, warns GlobalData
  • Is failure to adopt business process management putting the pharma industry at risk?

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS